European Patent Office

T 0578/21 (Compositions for treating inflammation in infants/NESTEC) of 20.01.2023

European Case Law Identifier
ECLI:EP:BA:2023:T057821.20230120
Date of decision
20 January 2023
Case number
T 0578/21
Online on
17 February 2023
Petition for review of
-
Application number
12770505.1
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
COMPOSITION FOR USE IN THE PROMOTION OF INTESTINAL ANGIOGENESIS AND OF NUTRIENT ABSORPTION AND OF ENTERAL FEEDING TOLERANCE AND/OR IN THE PREVENTION AND/OR TREATMENT OF INTESTINAL INFLAMMATION AND/OR IN THE RECOVERY AFTER INTESTINAL INJURY AND SURGERY
Applicant name
Société des Produits Nestlé S.A.
Opponent name
N.V. Nutricia
Board
3.3.09
Headnote
-
Relevant legal provisions
European Patent Convention Art 56European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Keywords
Auxiliary Request 5: Added subject-matter - (no); inventive step - (yes); admission of late submissions - (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1 to 9 according to auxiliary request 5, submitted with the reply to the statement setting out the grounds of appeal, and a description yet to be adapted.